Latest News

When close to half the companies in Japan have price-to-earnings ratios (or "P/E's") below 14x, you may consider Japan...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Golden Agri-Resources fair value estimate is S$0.25 With...

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...

The Shandong Molong Petroleum Machinery Company Limited ( HKG:568 ) share price has fared very poorly over the last...

Viewing insider transactions for Longfor Group Holdings Limited's ( HKG:960 ) over the last year, we see that insiders...

Key Insights The considerable ownership by individual investors in UJU Electronics indicates that they collectively...

Venture's (SGX:V03) stock is up by 7.4% over the past three months. However, its weak financial performance indicators...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

Investors who take an interest in Centurion Corporation Limited ( SGX:OU8 ) should definitely note that the Joint...

Key Insights Given the large stake in the stock by institutions, Lendlease Group's stock price might be vulnerable to...

Po Valley Energy Limited ( ASX:PVE ) insiders who purchased shares in the last 12 months were richly rewarded last...

Powerhouse Ventures Limited ( ASX:PVL ) shareholders have had their patience rewarded with a 26% share price jump in...

Wondering if Pembina Pipeline is still a smart buy at today’s price, or if most of the upside has already been baked in? Let us unpack what the market is really paying for here. The stock has drifted slightly lower in the short term, down 2.8% over the last week and 2.5% over the last month. It is still up 5.4% over the past year, 39.0% over three years, and 130.4% over five years, which hints at a long runway of value creation despite recent softness. Recent headlines have focused on...

As the Australian market navigates a festive atmosphere reminiscent of past highs, optimism remains palpable despite ongoing tech jitters and fluctuating commodity prices. In this context, identifying stocks that are undervalued relative to their intrinsic value can offer significant opportunities for investors looking to capitalize on potential market inefficiencies.

Caleres, Inc. ( NYSE:CAL ) will pay a dividend of $0.07 on the 9th of January. Based on this payment, the dividend...

Key Insights Given the large stake in the stock by institutions, Digimarc's stock price might be vulnerable to their...

Recently, SNDL Inc. renewed its share repurchase program of up to C$100 million and saw sentiment strengthen after reports that the Trump administration may push to reclassify marijuana to Schedule III in the US, a move that could ease tax and financing constraints across the cannabis industry. Although SNDL remains primarily focused on Canada, shifting expectations around US federal cannabis policy are increasingly influencing how investors view its long-term optionality and capital...

As the U.S. stock market experiences a retreat following delayed jobs data and higher-than-expected unemployment rates, investors are closely monitoring economic indicators and Federal Reserve decisions for future guidance. In such an environment, identifying stocks trading below their intrinsic value can present opportunities for those looking to invest wisely amid market fluctuations.

In the current landscape, major U.S. stock indices like the Dow Jones and S&P 500 have recently retreated, influenced by unexpected unemployment data and shifts in Federal Reserve interest rate policies. Despite these broader market challenges, small-cap stocks often present unique opportunities for investors seeking growth potential in under-the-radar companies. Identifying promising stocks requires an understanding of how these smaller companies can navigate economic fluctuations while...

Kyverna Therapeutics (KYTX) just delivered positive topline data from its registrational KYSA-8 trial in stiff person syndrome and paired that milestone with a planned $100 million follow on equity raise, a combination the market is watching closely. See our latest analysis for Kyverna Therapeutics. The news has turbocharged sentiment, with Kyverna’s latest share price at $10.82 after a 1 day share price return of 23.23 percent and a year to date share price return of 176.02 percent. This...

It hasn't been the best quarter for Stantec Inc. ( TSE:STN ) shareholders, since the share price has fallen 15% in that...